For the Inventor, By the Inventor

Enter assignee name

Doylestown, PA, United States of America

Baruch S. Blumberg Institute

USPTO Granted Patents = 16

CIPO Patents = 7

EPO Patents = 2

Trademarks = 1

Forward Citations = 46

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Timothy Michael Block (13 out of 36 patents)

Xiaodong Xu (9 out of 18 patents)

Andrea Cuconati (8 out of 9 patents)

4. Ju-Tao Guo (7 out of 10 patents)

5. Jinhong Chang (6 out of 9 patents)

6. Yanming Du (4 out of 10 patents)

7. Haitao Guo (3 out of 5 patents)

8. Dawei Cai (3 out of 3 patents)

9. Tong Xiao (3 out of 14 patents)

10. William Alvin Kinney (3 out of 65 patents)

11. Hong Ye (2 out of 24 patents)

12. Changhua Ji (2 out of 2 patents)

13. Harold R Almond (2 out of 14 patents)

14. Huagang Lu (2 out of 7 patents)

15. John Rogowsky (1 out of 1 patent)

16 patents: Sort by Forward Citations

1. 10913734 - Substituted aminothiazoles (2021-02-09),

2. 10421723 - 2,3-diacylated, 2- and 3-mono-acylated alkylated imino sugars exhibiting glucosidase inhibition and their method of use (2019-09-24),

3. 10214567 - Tagged hepadnavirus E antigen and its use in screening antiviral substances (2019-02-26),

4. 10143720 - Modulation of hepatitis B virus cccDNA transcription (2018-12-04),

5. 10087173 - Substituted aminothiazoles as inhibitors of cancers, including hepatocellular carcinoma, and as inhibitors of hepatitis virus replication (2018-10-02),

6. 10072047 - Tagged hepadnavirus e antigen and its use in screening antiviral substances (2018-09-11),

7. 9938236 - Antiviral agents against HBV infection (2018-04-10),

8. 9758477 - Sulfamoylbenzamide derivatives as antiviral agents against HBV infection (2017-09-12),

9. 9657013 - Inhibitors of hepatitis B virus covalently closed circular DNA formation and their method of use (2017-05-23),

10. 9623071 - Modulation of hepatitis B virus CCCDNA transcription (2017-04-18),

11. 9533990 - Inhibitors of secretion of hepatitis B virus antigens (2017-01-03),

12. 9399619 - Sulfamoylbenzamide derivatives as antiviral agents against HBV infection (2016-07-26),

13. 9168260 - Benzodiazepine compounds with anti-flavivirus activity (2015-10-27),

14. 9126937 - Alkylated imino sugars exhibiting glucosidase inhibition and their method of use (2015-09-08),

15. 9040488 - Imino sugar derivatives demonstrate potent antiviral activity and reduced toxicity (2015-05-26),

The Baruch S. Blumberg Institute is a research organization dedicated to advancing scientific understanding and medical breakthroughs in fields like virology, immunology, and cancer biology. By fostering collaborations between scientists, clinicians, and industry partners, the institute aims to develop and implement innovative solutions for improving human health. Through cutting-edge research, education, and outreach programs, the Blumberg Institute strives to make a positive impact on patients' lives and contribute to the advancement of medical knowledge.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

16 Patents

#2 in

#19,264 in

#36,617 in the World

Doylestown, PA, United States of America

Baruch S. Blumberg Institute

Forward Citations = 46

23 inventors:

Timothy Michael Block (13 out of 36 patents)

Xiaodong Xu (9 out of 18 patents)

Andrea Cuconati (8 out of 9 patents)

4. Ju-Tao Guo (7 out of 10 patents)

5. Jinhong Chang (6 out of 9 patents)

Please report any incorrect information to support@idiyas.com

Loading…